Rescue and repair of stalled ribosome damaged by ribosome-specific ribotoxins

被核糖体特异性核毒素损坏的停滞核糖体的拯救和修复

基本信息

项目摘要

Project Summary/Abstract Colicin E3 was the first ribotoxin to be characterized 50 years ago. It makes a single but precise cut of 16S rRNA in the decoding center of bacterial ribosome, resulting in stalled ribosome and eventual cell death. Over the last half of a century, it is unclear whether there exists a biological system that is able to reverse the ribosomal damage by colicin E3 to allow cell to survive. Employing approaches of bioinformatics, biochemistry, structural biology, and microbiology, we have uncovered a bacterial two- component system, RtcB and PrfH, as the antidote of colicin E3. Specifically, bacterial PrfH recognizes the damaged and stalled ribosome and performs ribosomal rescue. This is followed by RtcB repairing the damaged 30S ribosomal subunit. The sequential events described above are supported by abundant preliminary data from both our in vitro and in vivo studies. In this application, we plan to significantly expand our preliminary studies to systematically characterize the rescue and repair of bacterial ribosome with specific damage in the decoding center with the following three main aims: (1) We will provide insight into bacterial PrfH recognizing and rescuing the damaged and stalled 70S ribosome in vitro; (2) We will biochemically and structurally characterize bacterial RtcB in vitro, with the emphasis of PrfH-coupled RtcB repairing the damaged 30S ribosomal subunit; and (3) We will elucidate in vivo biological functions of RtcB- PrfH using an in vivo attenuated RNA damage system we have developed.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Raven H Huang其他文献

Raven H Huang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Raven H Huang', 18)}}的其他基金

Rescue and repair of stalled ribosome damaged by ribosome-specific ribotoxins
被核糖体特异性核毒素损坏的停滞核糖体的拯救和修复
  • 批准号:
    10615180
  • 财政年份:
    2022
  • 资助金额:
    $ 5.95万
  • 项目类别:
Rescue and repair of stalled ribosome damaged by ribosome-specific ribotoxins
被核糖体特异性核毒素损坏的停滞核糖体的拯救和修复
  • 批准号:
    10467347
  • 财政年份:
    2022
  • 资助金额:
    $ 5.95万
  • 项目类别:
Generation and application of second messenger molecules by SMODS and SAVED
SMODS和SAVED第二信使分子的生成和应用
  • 批准号:
    9916469
  • 财政年份:
    2020
  • 资助金额:
    $ 5.95万
  • 项目类别:
Generation and application of second messenger molecules by SMODS and SAVED
SMODS和SAVED第二信使分子的生成和应用
  • 批准号:
    10078261
  • 财政年份:
    2020
  • 资助金额:
    $ 5.95万
  • 项目类别:
Genome-wide profiling of RNA damage and repair in vivo
体内 RNA 损伤和修复的全基因组分析
  • 批准号:
    9751333
  • 财政年份:
    2016
  • 资助金额:
    $ 5.95万
  • 项目类别:
Genome-wide profiling of RNA damage and repair in vivo
体内 RNA 损伤和修复的全基因组分析
  • 批准号:
    9352862
  • 财政年份:
    2016
  • 资助金额:
    $ 5.95万
  • 项目类别:
Genome-wide profiling of RNA damage and repair in vivo
体内 RNA 损伤和修复的全基因组分析
  • 批准号:
    9177493
  • 财政年份:
    2016
  • 资助金额:
    $ 5.95万
  • 项目类别:
Structure and Function of the Elongator Complex
伸长复合体的结构和功能
  • 批准号:
    9325029
  • 财政年份:
    2014
  • 资助金额:
    $ 5.95万
  • 项目类别:
Structure and Function of the Elongator Complex
伸长复合体的结构和功能
  • 批准号:
    9130210
  • 财政年份:
    2014
  • 资助金额:
    $ 5.95万
  • 项目类别:
Structure and Function of the Elongator Complex
伸长复合体的结构和功能
  • 批准号:
    8698011
  • 财政年份:
    2014
  • 资助金额:
    $ 5.95万
  • 项目类别:

相似海外基金

A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
  • 批准号:
    24K02286
  • 财政年份:
    2024
  • 资助金额:
    $ 5.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
  • 批准号:
    2420924
  • 财政年份:
    2024
  • 资助金额:
    $ 5.95万
  • 项目类别:
    Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
  • 批准号:
    10596047
  • 财政年份:
    2023
  • 资助金额:
    $ 5.95万
  • 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
  • 批准号:
    10742028
  • 财政年份:
    2023
  • 资助金额:
    $ 5.95万
  • 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
  • 批准号:
    BB/X017540/1
  • 财政年份:
    2023
  • 资助金额:
    $ 5.95万
  • 项目类别:
    Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
  • 批准号:
    LP210301365
  • 财政年份:
    2023
  • 资助金额:
    $ 5.95万
  • 项目类别:
    Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
  • 批准号:
    10730832
  • 财政年份:
    2023
  • 资助金额:
    $ 5.95万
  • 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
  • 批准号:
    10659841
  • 财政年份:
    2023
  • 资助金额:
    $ 5.95万
  • 项目类别:
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
  • 批准号:
    576545-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 5.95万
  • 项目类别:
    Idea to Innovation
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
  • 批准号:
    BB/V016067/1
  • 财政年份:
    2022
  • 资助金额:
    $ 5.95万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了